Volume 21, issue 1, December 2022
229 articles in this issue
-
-
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
Authors (first, second and last of 17)
- Lisha Sun
- Yixiao Zhang
- Caigang Liu
- Content type: Research
- Open Access
- Published: 29 December 2022
- Article: 228
-
Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway
Authors (first, second and last of 9)
- Jia-Xing Zhang
- Yi Xu
- Sheng Ye
- Content type: Retraction Note
- Open Access
- Published: 28 December 2022
- Article: 227
-
Extracellular vesicle microRNAs contribute to Notch signaling pathway in T-cell acute lymphoblastic leukemia
Authors (first, second and last of 11)
- Tommaso Colangelo
- Patrizio Panelli
- Vincenzo Giambra
- Content type: Correspondence
- Open Access
- Published: 22 December 2022
- Article: 226
-
Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis
Authors (first, second and last of 6)
- Palanisamy Nallasamy
- Rama Krishna Nimmakayala
- Moorthy P. Ponnusamy
- Content type: Review
- Open Access
- Published: 22 December 2022
- Article: 225
-
CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug
Authors (first, second and last of 14)
- Yanping Liang
- Junjie Cen
- Jiaxing Zhang
- Content type: Research
- Open Access
- Published: 19 December 2022
- Article: 224
-
Retraction Note: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
Authors
- Sarita Saraswati
- Shakti Kumar
- Abdulqader A. Alhaider
- Content type: Retraction Note
- Open Access
- Published: 15 December 2022
- Article: 223
-
Editorial expression of concern: Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma
Authors (first, second and last of 14)
- Fei Wang
- Jin-Lian Yang
- Si-Ying Wang
- Content type: Editorial Expression of Concern
- Open Access
- Published: 15 December 2022
- Article: 222
-
Correction: NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
Authors (first, second and last of 8)
- Huanhuan Sun
- Hong Zhang
- Haiqing Ma
- Content type: Correction
- Open Access
- Published: 14 December 2022
- Article: 221
-
Biological and pharmacological roles of m6A modifications in cancer drug resistance
Authors (first, second and last of 10)
- Zaoqu Liu
- Haijiao Zou
- Xinwei Han
- Content type: Review
- Open Access
- Published: 14 December 2022
- Article: 220
-
Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure
Authors (first, second and last of 11)
- Rihao Qu
- Yuval Kluger
- Harriet M. Kluger
- Content type: Correspondence
- Open Access
- Published: 14 December 2022
- Article: 219
-
Correction: Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy
Authors (first, second and last of 8)
- Qiang Cai
- Shouhua Wang
- Zhiwei Quan
- Content type: Correction
- Open Access
- Published: 13 December 2022
- Article: 218
-
circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion
Authors (first, second and last of 8)
- Lina Gu
- Yang Sang
- Baoen Shan
- Content type: Research
- Open Access
- Published: 13 December 2022
- Article: 217
-
A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer
Authors (first, second and last of 10)
- Ting Guo
- Xiao-Huan Tang
- Jia-Fu Ji
- Content type: Correspondence
- Open Access
- Published: 12 December 2022
- Article: 216
-
Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling
Authors (first, second and last of 11)
- Celeste Rizzello
- Valeria Cancila
- Mario P. Colombo
- Content type: Research
- Open Access
- Published: 12 December 2022
- Article: 215
-
Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
Authors (first, second and last of 8)
- Barbara Nuvoli
- Sabrina Germoni
- Rossella Galati
- Content type: Retraction Note
- Open Access
- Published: 09 December 2022
- Article: 214
-
Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors
Authors (first, second and last of 11)
- Maria E. R. Garcia-Rendueles
- Gnana Krishnamoorthy
- James A. Fagin
- Content type: Research
- Open Access
- Published: 07 December 2022
- Article: 213
-
Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC
Authors (first, second and last of 11)
- Yige Sun
- Jie Yang
- Xilin Sun
- Content type: Research
- Open Access
- Published: 01 December 2022
- Article: 212
-
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
Authors (first, second and last of 12)
- Daniel Meraviglia-Crivelli
- Helena Villanueva
- Fernando Pastor
- Content type: Research
- Open Access
- Published: 28 November 2022
- Article: 211
-
Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer
Authors (first, second and last of 16)
- Xue Wang
- Han Cheng
- Zhaohui Huang
- Content type: Research
- Open Access
- Published: 14 November 2022
- Article: 210
-
Retraction Note to: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis
Authors (first, second and last of 10)
- Fengting Huang
- Wenying Chen
- Shineng Zhang
- Content type: Retraction Note
- Open Access
- Published: 11 November 2022
- Article: 209
-
Targeting the tumor stroma for cancer therapy
Authors (first, second and last of 5)
- Maosen Xu
- Tao Zhang
- Xiawei Wei
- Content type: Review
- Open Access
- Published: 02 November 2022
- Article: 208
-
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
Authors (first, second and last of 7)
- Qing-Fang Han
- Wen-Jia Li
- Shui-Jun Zhang
- Content type: Review
- Open Access
- Published: 01 November 2022
- Article: 207
-
NK cells and solid tumors: therapeutic potential and persisting obstacles
Authors (first, second and last of 6)
- Le Tong
- Carlos Jiménez-Cortegana
- Andreas Lundqvist
- Content type: Review
- Open Access
- Published: 01 November 2022
- Article: 206
-
Correction: CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
Authors (first, second and last of 8)
- Fei Xie
- Chao Huang
- Guosong Jiang
- Content type: Correction
- Open Access
- Published: 01 November 2022
- Article: 205
-
Antioxidants in brain tumors: current therapeutic significance and future prospects
Authors (first, second and last of 10)
- Xuchen Qi
- Saurabh Kumar Jha
- Kaijian Hou
- Content type: Review
- Open Access
- Published: 28 October 2022
- Article: 204
-
Correction: Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K
Authors (first, second and last of 11)
- Gui Ren
- Qifei Tian
- Daiming Fan
- Content type: Correction
- Open Access
- Published: 25 October 2022
- Article: 203
-
Correction: Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122
Authors (first, second and last of 13)
- Rui Su
- Shuo Cao
- Yixue Xue
- Content type: Correction
- Open Access
- Published: 22 October 2022
- Article: 202
-
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
Authors (first, second and last of 18)
- Chunrun Qu
- Hao Zhang
- Quan Cheng
- Content type: Review
- Open Access
- Published: 19 October 2022
- Article: 201
-
The single cell transcriptional landscape of esophageal adenocarcinoma and its modulation by neoadjuvant chemotherapy
Authors (first, second and last of 6)
- Wayne Croft
- Richard P. T. Evans
- Paul Moss
- Content type: Research
- Open Access
- Published: 17 October 2022
- Article: 200
-
Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma
Authors (first, second and last of 18)
- Tilman L. B. Hölting
- Florencia Cidre-Aranaz
- Maximilian M. L. Knott
- Content type: Research
- Open Access
- Published: 13 October 2022
- Article: 199
-
The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition
Authors (first, second and last of 10)
- Peng Liu
- Zehao Wang
- Hailin Tang
- Content type: Research
- Open Access
- Published: 12 October 2022
- Article: 198
-
Two circPPFIA1s negatively regulate liver metastasis of colon cancer via miR-155-5p/CDX1 and HuR/RAB36
Authors (first, second and last of 6)
- Haein Ji
- Tae Won Kim
- Hyeon Ho Kim
- Content type: Research
- Open Access
- Published: 12 October 2022
- Article: 197
-
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Authors (first, second and last of 6)
- Zhi Zhu
- A. J. Robert McGray
- Zong Sheng Guo
- Content type: Review
- Open Access
- Published: 12 October 2022
- Article: 196
-
Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis
Authors (first, second and last of 9)
- Emilie Renaud
- Kristina Riegel
- Krishnaraj Rajalingam
- Content type: Correspondence
- Open Access
- Published: 10 October 2022
- Article: 195
-
The journey of CAR-T therapy in hematological malignancies
Authors
- Junru Lu
- Guan Jiang
- Content type: Review
- Open Access
- Published: 08 October 2022
- Article: 194
-
Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer
Authors (first, second and last of 9)
- Xueli Tian
- Rui Wang
- Zigang Dong
- Content type: Correspondence
- Open Access
- Published: 06 October 2022
- Article: 193
-
Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop
Authors (first, second and last of 18)
- Yongzhen Mo
- Yumin Wang
- Bo Xiang
- Content type: Research
- Open Access
- Published: 05 October 2022
- Article: 192
-
Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase
Authors (first, second and last of 18)
- Nastasja Merle
- Sabrina Elmshäuser
- Thorsten Stiewe
- Content type: Research
- Open Access
- Published: 03 October 2022
- Article: 191
-
CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment
Authors (first, second and last of 20)
- Zongfu Pan
- Tong Xu
- Minghua Ge
- Content type: Research
- Open Access
- Published: 03 October 2022
- Article: 190
-
Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition
Authors (first, second and last of 4)
- Roger J. Daly
- Andrew M. Scott
- Matthias Ernst
- Content type: Review
- Open Access
- Published: 29 September 2022
- Article: 189
-
Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway
Authors (first, second and last of 8)
- Mingjun Yu
- Yixue Xue
- Yunhui Liu
- Content type: Retraction Note
- Open Access
- Published: 29 September 2022
- Article: 188
-
Correction: Histone acetyltransferase PCAF Up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling
Authors (first, second and last of 7)
- Xin Zheng
- Xiaohong Gai
- Qingguang Liu
- Content type: Correction
- Open Access
- Published: 28 September 2022
- Article: 187
-
The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy
Authors (first, second and last of 12)
- Lu Liang
- Huiyu Cen
- Lingmin Zhang
- Content type: Research
- Open Access
- Published: 28 September 2022
- Article: 186
-
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
Authors (first, second and last of 20)
- Vivian Changying Jiang
- Dapeng Hao
- Michael Wang
- Content type: Research
- Open Access
- Published: 26 September 2022
- Article: 185
-
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Authors (first, second and last of 5)
- Yuze Wu
- Ming Yi
- Kongming Wu
- Content type: Review
- Open Access
- Published: 26 September 2022
- Article: 184
-
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Authors (first, second and last of 27)
- Claudia Buhigas
- Anne Y. Warren
- Daniel S. Brewer
- Content type: Research
- Open Access
- Published: 22 September 2022
- Article: 183
-
Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming
Authors (first, second and last of 10)
- Yuanzheng Liang
- Haiyan He
- Liang Wang
- Content type: Research
- Open Access
- Published: 22 September 2022
- Article: 182
-
Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma
Authors (first, second and last of 9)
- Mengwei Li
- Guangxiang Liu
- Hanmei Xu
- Content type: Research
- Open Access
- Published: 19 September 2022
- Article: 181
-
Ligands stimulating antitumour immunity as the next G-quadruplex challenge
Authors (first, second and last of 4)
- Giulia Miglietta
- Jessica Marinello
- Giovanni Capranico
- Content type: Review
- Open Access
- Published: 17 September 2022
- Article: 180